Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.57x is 61% below its 5-year average of 4.05x, near the low end of its 5-year range (-0.71x–54.97x).
10.86% below its 12-month average of 1.76x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 2.15x.
INTEREST COVERAGE RATIO
1.57x
INTEREST COVERAGE RATIO AVG TTM
1.76x
INTEREST COVERAGE RATIO AVG 3Y
1.97x
INTEREST COVERAGE RATIO AVG 5Y
4.05x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-10.86%
CURRENT VS 3Y AVG
-20.35%
CURRENT VS 5Y AVG
-61.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.65x
median of 467 covered companies
CURRENT VS SECTOR MEDIAN
+127.79%
vs the sector median at left
Astrana Health, Inc.
Market Cap
$1.84B
Interest Coverage Ratio
1.57x
TTM Avg
1.76x
3Y Avg
1.97x
5Y Avg
4.05x
Market Cap
$1.83B
Interest Coverage Ratio
24.98x
TTM Avg
24.98x
3Y Avg
24.98x
5Y Avg
24.98x
Market Cap
$1.84B
Interest Coverage Ratio
N/A
TTM Avg
1.77x
3Y Avg
2.62x
5Y Avg
35.29x
Market Cap
$1.86B
Interest Coverage Ratio
-6.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.82B
Interest Coverage Ratio
13.10x
TTM Avg
134.00x
3Y Avg
134.00x
5Y Avg
76.60x
Market Cap
$1.89B
Interest Coverage Ratio
-0.40x
TTM Avg
732.40x
3Y Avg
732.40x
5Y Avg
732.40x
Market Cap
$1.79B
Interest Coverage Ratio
-206.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.90B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Astrana Health, Inc. (ASTH) | $1.84B | 1.57x | 1.76x | 1.97x | 4.05x |
| Novavax, Inc. (NVAX)vs › | $1.83B | 24.98x | 24.98x | 24.98x | 24.98x |
| Azenta, Inc. (AZTA)vs › | $1.84B | N/A | 1.77x | 2.62x | 35.29x |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | -6.63x | N/A | N/A | N/A |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 13.10x | 134.00x | 134.00x | 76.60x |
| Novocure Ltd (NVCR)vs › | $1.80B | N/A | 1.68x | 1.68x | 1.68x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -0.40x | 732.40x | 732.40x | 732.40x |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | -206.92x | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | N/A | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.78B | -596.74x | N/A | N/A | N/A |
Interest Coverage
1.6x
Debt/Equity
1.18
Current Ratio
1.23
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.15x |
| 2026-03-31 | 1.77x |
| 2025-12-31 | 1.05x |
| 2025-09-30 | 1.08x |
| 2025-06-30 | 2.76x |
| 2025-03-31 | 2.82x |
| 2024-12-31 | 0.09x |
| 2024-09-30 | 3.21x |
| 2024-06-30 | 3.50x |
| 2024-03-31 | 3.97x |
| 2023-12-31 | -0.71x |
| 2023-09-30 | 10.34x |
| 2023-06-30 | 7.44x |
| 2023-03-31 | 6.84x |
| 2022-12-31 | 4.89x |
| 2022-09-30 | 20.68x |
| 2022-06-30 | 8.30x |
| 2022-03-31 | 24.43x |
| 2021-12-31 | 2.14x |
| 2021-09-30 | 54.97x |
| 2021-06-30 | 11.33x |
